Remicade (infliximab) - J&J
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
tofacitinib - Generic mfg.
Stelara (ustekinumab) - J&J
Jyseleca (filgotinib) - Gilead
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Simponi (golimumab) - J&J
Entyvio (vedolizumab) - Takeda
Zeposia (ozanimod) - BMS
Velsipity (etrasimod) - Pfizer
http://clinicaltrials.gov/ct2/show/NCT07177209
 
May 15, 2026
 
Prev Next